Antihistamine Pretreatment to Reduce Incidence of Withdrawal Movement After Rocuronium Injection
Journal of Korean Medical Science
; : 879-882, 2009.
Article
en En
| WPRIM
| ID: wpr-223643
Biblioteca responsable:
WPRO
ABSTRACT
The purpose of this study was to determine the effectiveness of antihistamine therapy for withdrawal movements caused by rocuronium injection. One hundred seventy one ASA I-II adults undergoing elective surgery were randomly assigned to one of two groups. Patients in the control group (Group C) were premedicated with 2 mL normal saline, and those in the antihistamine group (Group A) were pre-medicated with 2 mL (45.5 mg) pheniramine maleate. After the administration of thiopental sodium 5 mg/kg, rocuronium 0.6 mg/kg was injected. Withdrawal movements were assessed using a four-grade scale. The administration of antihistamine reveals lower grade of withdrawal movement after rocuronium injection.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Dolor
/
Feniramina
/
Tiopental
/
Dimensión del Dolor
/
Método Doble Ciego
/
Incidencia
/
Fármacos Neuromusculares no Despolarizantes
/
Anestésicos Intravenosos
/
Antagonistas de los Receptores Histamínicos H1
/
Androstanoles
Tipo de estudio:
Clinical_trials
/
Incidence_studies
/
Prognostic_studies
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Journal of Korean Medical Science
Año:
2009
Tipo del documento:
Article